Arthritis is one of the most common chronic conditions affecting millions of people worldwide. Yet, many fail to recognize ...
Psoriatic arthritis (PsA) is a chronic inflammatory condition that affects approximately 112 per 100,000 adults worldwide. It ...
Treatment with deucravacitinib in patients with active PsA showed higher response rates and improvement in quality of life ...
Although metabolic syndrome is associated with higher PsA disease activity, it is not associated with higher PsA-related ...
The following is a summary of “Potentially Avoidable Emergency Department Utilization by Persons With Psoriatic Arthritis and ...
Biologic disease-modifying antirheumatic drugs (bDMARDs) do not appear to negatively impact fertility among women with rheumatoid arthritis (RA) or psoriatic arthritis (PsA), according to study ...
Celltrion, Inc., a leading global biopharmaceutical company, announced today that its infliximab biosimilar will be marketed in Canada under the new b ...